Advanced search
Publication Cover
Platelets Volume 10, 1999 - Issue 4
Submit an article Journal homepage
17
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of anti-beta2 glycoprotein-I antibody in patients with primary or secondary immune thrombocytopenia

Kyung Soon Song, Young Ah Kim, Hyon Suk Kim, Jae Gyun Lim, Hyun Kyung Kim, Kwang Il Park, Quehn Park Department of Clinical Pathology, Yonsei University College of Medicine, Seoul, Korea
Pages 219-222 | Published online: 07 Jul 2009

  • McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
  • Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: Association with anti-cardiolipin antibodies. Br J Haematol 1985; 59: 227-30.
  • Firkin BG, Booth P, Hendrix L, Howard MA. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. Am J Hematol 1978; 5: 81-92.
  • McNeil HP, Simpson RJ, Chesterman CN. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: P2 glycoprotein-I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
  • GAIH M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
  • Koike T, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor (s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-8.
  • Koike T, Matsuura E. What is the 'true' antigen for anti-cardiolipin antibodies? Lancet 1991; 337: 671-2.
  • Viard JP, Amoura Z, Bach JF. Association of anti-ß2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93:181-6.
  • Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol 1985; 22: 260-88.
  • Hathaway WE, Gootnight SH. Immune thrombocytopenia. In: Disorders of Hemostasls and Thrombosis. New York: McGrawHiII, 1993; 83-93.
  • Kelton JG, Gibbons ST. Autoimmune platelet destruction: Idiopathic thrombocytopenic purpura. Semin Thromb Haemostas 1982; 8: 83-104.
  • Stasi R, Stipa E, Mas! M, Oliva F, Sciarra A, Perrotti A, Olivieri M, Zaccari G, Gandolfo GM, GaIIi M, Barbui T, Papa G. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203-8.
  • Nomura S, Yanabu M, Miyake T, Miyazaki Y, Kido H, Kagawa H, Fukuhara S, Komiyama Y, Matsuura E, Koike T. Relationship of microparticles with P2 glycoprotein-I and P-selectin positivity to anti-cardiolipin antibodies in immune thrombocytopenic purpura. Blood 1994; 84: 4203-8.
  • Rosenfeld CS, Bodensteiner DC. Detection of platelet alloantibodies by flow cytometry: Characterization and clinical significance. Am J Clin Pathol 1986; 85: 207-12.
  • Shi W, Chong BH, Hogg PJ, Chesterman CN. Anti-cardiolipin antibodies block the inhibition by P2 glycoprotein-I of the factor Xa generating activity of platelets. Thromb Haemostas 1993; 70: 342-5.
  • Hasselaar P, Derksen RHWM, Blokzijl L, de Groot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemostas 1990; 63: 169-73.
  • Hisham E, Keil L, DeBari V. Analytical and clinical relationships between IgG autoantibodies to P2 glycoprotein-I and anticardiolipin antibodies. J Rheumatol 1995; 22: 2233-7.
  • Escalante A, Brey RL, Mitchell BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995; 98: 559-65.
  • McNeil T, Purdy G, Mackie IJ, Machin SJ, Isenberg DA. The use of an anti-ß2 glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Hematol 1995; 91: 471-3.
  • Cohen AJ, Philips TM, Kessler CM. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 175-80.
  • Cohen H, Mackie IJ, Anagnostopoulos N, Savage GF. Lupus anticoagulant, anti-cardiolipin antibodies, and human immunodeficiency virus in haemophilia. J Clin Pathol 1989; 42: 629-33.
  • Canoso RT, Zon LI, Groopman JE. Anti-cardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987; 65: 495-8.
  • Campbell AL, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effects of anti-cardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemostas 1995; 73: 529-34.
  • Misra R, Venables PJW, Watkin RPF, Maini RN. Autoimmunity to cardiolipin in infectious mononucleosis. Lancet 1987; 2: 629.
  • Gold JE, Haubenstock A, Zalusky R. Lupus anticoagulant and AIDS. N Engl J Med 1986; 59: 449-56.
  • Colaco CB, Male DK. Antiphospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59: 449-56.
  • Vaarala O, Palosuo T, Kleemola M, Aho K. Anti-cardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41: 8-15.
  • Young CM. Antiphospholipid antibodies: More than just a disease marker? Immunol Today 1990; 11: 60-5.
  • Aoki K, Matsuura E, Sasa H, Yagami Y, Dudkiewicz AB, Gleicher N. ß2 glycoprotein-I dependent and independent anti-cardiolipin antibodies in healthy pregnant women. Hum Reprod 1994; 9: 1849-51.
  • Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-22.
  • Forastiero RR, Martinuzzo ME, Kordich LC, Carreras LO. Reactivity to ß2 glycoprotein-1 clearly differentiates anti-cardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemostas 1996; 75: 717-20.
  • Quintarelli C, Ferro D, Valesini G, Basili S, Tassone G, Violi F. Prevalence of lupus anticoagulant in patients with cirrhosis: Relationship with beta-2 glycoprotein I plasma levels. J Hepatol 1994; 21: 1086-91.
  • Brandt JT. Antibodies to ß2 glycoprotein-I inhibit phospholipid dependent coagulation reactions. Thromb Haemostas 1993; 70: 598-602.
  • Nimpf J, Wurm H, Kostner GM. ß2 glycoprotein-I (apo H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerose 1987; 63: 109-14.
  • Shi W, Chong BH, Chesterman CN. ß2 glycoprotein-I is a requirement for anti-cardiolipin antibodies binding to activated platelets: Differences with lupus anticoagulants. Blood 1993; 81: 1255-62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.